InterCure Overview
- Year Founded
-
1994
- Status
-
Public
- Employees
-
320
- Stock Symbol
-
INCR
- Investments
-
9
- Share Price
-
$1.52
- (As of Friday Closing)
InterCure General Information
Description
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
Contact Information
Website
www.canndoc.comCorporate Office
- Number 85 Medinat Hayehudim
- Herzliya
- Israel
Corporate Office
- Number 85 Medinat Hayehudim
- Herzliya
- Israel
InterCure Stock Performance
As of 20-Jun-2025, InterCure’s stock price is $1.52. Its current market cap is $82.9M with 54.5M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.52 | $1.50 | $1.17 - $2.62 | $82.9M | 54.5M | 12.6K | -$0.40 |
InterCure Financials Summary
As of 31-Dec-2024, InterCure has a trailing 12-month revenue of $64M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 107,853 | 107,853 | 80,132 | 158,062 |
| Revenue | 64,050 | 64,050 | 95,967 | 115,568 |
| EBITDA | (14,483) | (14,483) | (7,902) | 20,631 |
| Net Income | (18,180) | (18,180) | (16,723) | 13,326 |
| Total Assets | 208,763 | 208,763 | 207,205 | 271,852 |
| Total Debt | 57,874 | 57,874 | 51,544 | 72,406 |
InterCure Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
InterCure Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
InterCure Patents
InterCure Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2574642-A1 | Apparatus and method for breathing pattern determination using a non-contact microphone | Inactive | 23-Jul-2004 | ||
| AU-2005264165-A1 | Apparatus and method for breathing pattern determination using a non-contact microphone | Inactive | 23-Jul-2004 | ||
| EP-1804649-A2 | Apparatus and method for breathing pattern determination using a non-contact microphone | Inactive | 23-Jul-2004 | ||
| EP-1804649-A4 | Apparatus and method for breathing pattern determination using a non-contact microphone | Inactive | 23-Jul-2004 | ||
| AU-2003286409-A1 | Apparatus and method for beneficial modification of biorhythmic activity | Active | 13-Dec-2002 | A61B5/486 |
InterCure Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
InterCure Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
InterCure Investments & Acquisitions (9)
InterCure’s most recent deal was a Merger/Acquisition with Leon Pharm for . The deal was made on 01-Jun-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Leon Pharm | 01-Jun-2024 | Merger/Acquisition | Pharmaceuticals | ||
| Cannomed (2 Medical Cannabis Dispensing Pharmacies and Patient Support Center) | 02-Sep-2021 | Corporate Asset Purchase | Therapeutic Devices | ||
| Pharmazone (Raanana) | 18-May-2021 | Merger/Acquisition | Distributors (Healthcare) | ||
| Subversive Acquisition | 23-Apr-2021 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) | ||
| Here World | 28-Jul-2020 | Merger/Acquisition | Other Healthcare Services |
InterCure Exits (1)
InterCure’s most recent exit was on 17-Feb-2015 from Regenera Pharma. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Regenera Pharma | 17-Feb-2015 | Completed |
|
InterCure Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Leon Pharm | Tel Aviv, Israel | 1988 |
InterCure FAQs
-
When was InterCure founded?
InterCure was founded in 1994.
-
Where is InterCure headquartered?
InterCure is headquartered in Herzliya, Israel.
-
What is the size of InterCure?
InterCure has 320 total employees.
-
What industry is InterCure in?
InterCure’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is InterCure a private or public company?
InterCure is a Public company.
-
What is InterCure’s stock symbol?
The ticker symbol for InterCure is INCR.
-
What is the current stock price of InterCure?
As of 20-Jun-2025 the stock price of InterCure is $1.52.
-
What is the current market cap of InterCure?
The current market capitalization of InterCure is $82.9M.
-
What is InterCure’s current revenue?
The trailing twelve month revenue for InterCure is $64M.
-
What is InterCure’s annual earnings per share (EPS)?
InterCure’s EPS for 12 months was -$0.40.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
